ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ORAGENICS, INC. (OGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 20 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-13
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 0.00 shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 20.00 shares, a 99.99% decline year-over-year.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was -214.73K shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 223.87K shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 2.18K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 20.00 shares 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 20.00 shares 10-Q · filed 2026-05-08 | |||
| 2025-06-30 | -214.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 9.14K shares 10-Q · filed 2025-08-08 | ||
| 2025-03-31 | 223.87K shares 10-Q · filed 2025-05-09 | |||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 17.15K shares 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | 17.15K shares 10-Q · filed 2024-08-09 | |||
| 2022-09-30 | 0.00 shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2023-04-14 | 4.50K shares 10-Q/A · filed 2023-04-14 | ||
| 2022-06-30 | 4.50K shares 10-Q/A · filed 2023-04-14 | |||
| 2021-12-31 | 2.18K shares 10-K/A · filed 2022-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |